Celiac disease is a chronic and multiorgan autoimmune disease that affects the small bowel in genetically predisposed persons due to the ingestion of gluten1. It can present a wide range of symptoms such as anemia, vague abdominal symptoms, esophagitis, neuropathy, ataxia, depression, short stature, osteomalacia, and multiple others.1 For the majority of patients, their celiac disease remains undiagnosed.1
We would like to share this recent review on the use of tissue transglutaminase antibody titers and use in the diagnosis of celiac disease.
Products are for professional/laboratory use only.
TDM in Chronic Inflammatory Diseases (CID)
Biologic therapies, and notably Monoclonal antibodies (mAbs) and Fusion Proteins (FP), have revolutionised the management of CID, such as Inflammatory Bowel Disease, Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriasis and Psoriatic Arthritis that affect millions of people worldwide.
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
Phadia Prime is the operator software developed for the Phadia Laboratory Systems: Phadia™ 100, Phadia™ 200, Phadia™ 250, Phadia™ 1000, Phadia™ 2500 series and Phadia™ 5000 series of instrument.
EliA LKM-1 measures antibodies against LKM-1 as an aid in the diagnosis of autoimmune hepatitis type 2 and is the first EliA test for this autoimmune liver disease. It is complementary to the already available EliA M2 that supports the diagnosis of primary biliary cholangitis.
Products are for professional/laboratory use only.
White paper: The Serum Tryptase Test – Use in Clinical Hematology
Wolfgang R. Sperr & Peter Valent, Medicaly University of Vienna
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
When each new lot number of kits is received, the QC Record Sheet will be loaded onto the website page for easy downloading. QC Record Sheets will remain accessible on the website to allow retrospective access if required.
Products are for professional/laboratory use only. Asthma is a serious respiratory condition affecting both children and adults across Australia and New Zealand. Over 2.5 million (about 1 in 9) Australians have asthma with more children than adults affected. There are over 400 asthma deaths each year in Australia alone.1
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
Phadia EliA autoimmune tests offer a broad and expanding portfolio of tests with excellent clinical performance designed to aid in the diagnosis of a wide range of autoimmune diseases.